Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
2603 Results for "
THR
" in MedChemExpress (MCE) Product Catalog:
Products (2603)
2603 Results for "THR" in MCE Product Catalog:
145
145 Publications Verification
Cat. No.: HY-A0190
CAS No.: 17650-98-5
Synonyms: Ceruletide; Cerulein; FI-6934
Category:
Cardiovascular Disease Alkaloids Animals Disease Research Fields Endocrinology Indole Alkaloids
Target:
98
98 Cited Publications
Cat. No.: HY-P1061
CAS No.: 867021-83-8
Research Areas:
98
98 Cited Publications
Cat. No.: HY-P1061A
CAS No.: 2803948-60-7
Research Areas:
70
Target:
Research Areas:
70
70 Cited Publications
Synonyms: Exenatide acetate
Target:
Research Areas:
70
70 Cited Publications
Synonyms: Z-IE(OMe)TD(OMe)-FMK
45
45 Cited Publications
Research Areas:
45
45 Cited Publications
Cat. No.: HY-114118A
Purity: 99.92%
Research Areas:
45
45 Cited Publications
Research Areas:
44
44 Cited Publications
Cat. No.: HY-16966
CAS No.: 1884220-36-3
SBI-0206965 is a potent, selective and cell permeable autophagy kinase ULK1 inhibitor with IC50s of 108 nM for ULK1 kinase and 711 nM for the highly related kinase ULK2. SBI-0206965 is also an AMPK inhibitor that can paradoxically increase Thr172 phosphorylation .
42
42 Cited Publications
Cat. No.: HY-P0014
CAS No.: 204656-20-2
Target:
Research Areas:
42
42 Cited Publications
Cat. No.: HY-P0014B
Target:
Research Areas:
32
Target:
26
Category:
Infection Microorganisms Macrolide Antibiotics Antibiotics Mammalian Cell Culture Disease Research Antibacterial Disease Research Fields
Target:
23
23 Cited Publications
Synonyms: MGL-3196; VIA-3196
Target:
Research Areas:
Resmetirom (MGL-3196) is a highly selective and orally active thyroid hormone receptor β (THR-β) agonist with an EC50 value of 0.21 μM. Resmetirom can be used for the study of noncirrhotic nonalcoholic steatohepatitis .
17
17 Cited Publications
Synonyms: LY2228820 dimesylate
Research Areas:
Ralimetinib dimesylate (LY2228820 dimesylate) is a selective, ATP-competitive inhibitor of p38 MAPK α/β with IC50s of 5.3 and 3.2 nM, respectively. Ralimetinib (LY2228820) selectively inhibits phosphorylation of MK2 (Thr334), with no effect on phosphorylation of p38a MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc.
17
17 Cited Publications
Cat. No.: HY-P0233
CAS No.: 20449-79-0
Target:
Research Areas:
17
17 Cited Publications
Cat. No.: HY-P0233A
Target:
17
Research Areas:
16
Target:
Research Areas:
Cardiovascular Disease Inflammation/Immunology Endocrinology Cancer
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
